NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 54 filers reported holding NEXTCURE INC in Q3 2022. The put-call ratio across all filers is 3.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,078 | -43.8% | 58,200 | -21.6% | 0.00% | – |
| Q2 2023 | $133,560 | -15.5% | 74,200 | -30.5% | 0.00% | – |
| Q1 2023 | $158,064 | -21.2% | 106,800 | -24.9% | 0.00% | -100.0% |
| Q4 2022 | $200,643 | -52.3% | 142,300 | -7.1% | 0.00% | 0.0% |
| Q3 2022 | $421,000 | -13.6% | 153,200 | +47.9% | 0.00% | 0.0% |
| Q2 2022 | $487,000 | -3.2% | 103,600 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $503,000 | -47.2% | 103,500 | -34.9% | 0.00% | -50.0% |
| Q4 2021 | $953,000 | -28.9% | 158,900 | -20.2% | 0.00% | -33.3% |
| Q3 2021 | $1,341,000 | +75.1% | 199,000 | +108.6% | 0.00% | +50.0% |
| Q2 2021 | $766,000 | -32.7% | 95,400 | -16.2% | 0.00% | -33.3% |
| Q1 2021 | $1,139,000 | +22.2% | 113,800 | +33.1% | 0.00% | +50.0% |
| Q4 2020 | $932,000 | -38.9% | 85,500 | -50.7% | 0.00% | -50.0% |
| Q3 2020 | $1,525,000 | +131.8% | 173,300 | +464.5% | 0.00% | +100.0% |
| Q2 2020 | $658,000 | – | 30,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 1,581,311 | $4,186,000 | 0.48% |
| Sofinnova Investments, Inc. | 2,671,856 | $7,348,000 | 0.43% |
| Long Focus Capital Management, LLC | 556,105 | $1,529,000 | 0.15% |
| DAFNA Capital Management LLC | 187,696 | $516,000 | 0.14% |
| Orbimed Advisors | 2,711,013 | $7,455,000 | 0.14% |
| Sio Capital Management, LLC | 130,000 | $358,000 | 0.11% |
| FNY Investment Advisers, LLC | 48,000 | $132,000 | 0.09% |
| Privium Fund Management (UK) Ltd | 24,400 | $67,000 | 0.08% |
| Minerva Advisors LLC | 31,713 | $87,000 | 0.07% |
| Krensavage Asset Management, LLC | 31,298 | $86,000 | 0.03% |